Phathom Pharmaceuticals, Inc. PHAT Ratios & Valuation
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 84.9%-1.3pp | 87.1%+1.5pp | 87.2%+3.7pp | 86.9%— | 86.2%— | |
| Operating margin | -47.1%+303pp | -91.4%+411pp | -145%+951pp | -235.9%— | -349.8%— | |
| Net margin | -76.8%+346pp | -126.3%+479pp | -186.5%+1,106pp | -289.5%— | -422.4%— | |
| Efficiency | ||||||
| Asset turnover | 0.7×+0.4× | 0.5×+0.4× | 0.5×+0.4× | 0.4×+0.4× | 0.3×+0.2× | |
| Liquidity | ||||||
| Current ratio | 2.2×-1.4× | 1.7×-2.5× | 2.2×-3.5× | 2.4×-4.1× | 3.6×-4.3× | |
| Per Share | ||||||
| Book value per share | -$4.11+12.7% | -$6.01-49.7% | -$5.76-98.8% | -$5.60-40.2% | -$4.70-84.8% | |
| Valuation | ||||||
| Market capitalization | $846.21M+16.3% | $1.18B+113% | $835.01M-21.1% | $681.39M+13.3% | $436.62M-28.2% | |
| Price / sales | 4.1×-4.8× | 6.7×-3.3× | 5.7×-34.6× | 6×— | 5.3×— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Phathom Pharmaceuticals, Inc.'s profit margins?
- Phathom Pharmaceuticals, Inc. (PHAT) runs a 84.9% gross margin and a -47.1% operating margin, with a -76.8% net margin.
- Where do Phathom Pharmaceuticals, Inc.'s ratios come from?
- Every ratio is computed from Phathom Pharmaceuticals, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
